AnalystsAndy ChenAndy Chen's Stock Forecasts
AnalystsAndy Chen
Sectors:
Industries:
Analyst Ranking
Top 15%
#763 out of 5327 analysts
Average Return
+34.17%
Win Rate
57%16 out of 28
Risk vs Reward
Poor
Good
Andy Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Alpine Immune Sciences IncALPN | +546.47% | $10.05 | $64.97 | 2023-10-18 - 2024-05-17 | Strong Buy |
Insmed IncINSM | +175.86% | $28.75 | $79.31 | 2024-02-15 - 2025-02-14 | Buy |
Zenas Biopharma IncZBIO | +157.44% | $7.66 | $19.72 | 2025-02-04 - 2026-02-03 | Buy |
Oruka Therapeutics IncORKA | +143.14% | $14.21 | $34.55 | 2025-02-04 - 2026-02-03 | Buy |
Intellia Therapeutics IncNTLA | +92.05% | $7.92 | $15.21 | 2025-04-21 - 2026-04-20 | Buy |
Andy Chen Analyst Color
Get additional color on Andy Chen's coverage of popular stocks
Andy Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Intellia Therapeutics IncNTLA | 2 | Sell | $9.00 | -17.58% | Downgrades | 5 days ago |
Sarepta Therapeutics IncSRPT | 1 | Buy | $27.00 | +60.43% | Upgrades | 12 days ago |
Palisade Bio IncPALI | 1 | Buy | $7.00 | +266.49% | Initiates Coverage On | 3 months ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $48.00 | +163.59% | Initiates Coverage On | 3 months ago |
Dianthus Therapeutics IncDNTH | 1 | Buy | $98.00 | -2.97% | Initiates Coverage On | 3 months ago |
Pharvaris NvPHVS | 1 | Buy | $42.00 | +25.19% | Initiates Coverage On | 3 months ago |
Moonlake ImmunotherapeuticsMLTX | 2 | Buy | $24.00 | +25.98% | Upgrades | 4 months ago |
Vera Therapeutics IncVERA | 2 | Buy | $88.00 | +137.90% | Upgrades | 4 months ago |
Immunovant IncIMVT | 2 | Buy | $50.00 | +25.25% | Upgrades | 6 months ago |
Vertex Pharmaceuticals IncVRTX | 1 | Buy | $548.00 | +14.05% | Upgrades | 6 months ago |
Verona Pharma PLCVRNA | 1 | Buy | $170.00 | N/A | Initiates Coverage On | a year ago |
Bridgebio Pharma IncBBIO | 1 | Buy | $49.00 | N/A | Initiates Coverage On | a year ago |
Avidity Biosciences IncRNAM | 1 | Buy | $55.00 | N/A | Initiates Coverage On | a year ago |
Oruka Therapeutics IncORKA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | a year ago |
Zenas Biopharma IncZBIO | 1 | Buy | $19.00 | N/A | Initiates Coverage On | a year ago |
Argenx SeARGX | 1 | Buy | $697.00 | N/A | Upgrades | 2 years ago |
Celldex Therapeutics IncCLDX | 1 | Buy | $51.00 | N/A | Reiterates | 2 years ago |
Kymera Therapeutics IncKYMR | 1 | Buy | $65.00 | N/A | Upgrades | 2 years ago |
Roivant Sciences LtdROIV | 1 | Buy | $17.00 | N/A | Initiates Coverage On | 2 years ago |
Insmed IncINSM | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Rapt Therapeutics IncRAPT | 2 | Buy | $312.00 | N/A | Initiates Coverage On | 2 years ago |
Alpine Immune Sciences IncALPN | 1 | Strong Buy | $18.00 | N/A | Initiates Coverage On | 3 years ago |
Affimed NvAFMDQ | 1 | Strong Buy | $60.00 | N/A | Assumes | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.